Invention Grant
US08728732B2 Global DNA hypomethylation and biomarkers for clinical indications in cancer
有权
全球DNA低甲基化和癌症临床适应症生物标志物
- Patent Title: Global DNA hypomethylation and biomarkers for clinical indications in cancer
- Patent Title (中): 全球DNA低甲基化和癌症临床适应症生物标志物
-
Application No.: US13408338Application Date: 2012-02-29
-
Publication No.: US08728732B2Publication Date: 2014-05-20
- Inventor: Rafael Guerrero-Preston , David Sidransky
- Applicant: Rafael Guerrero-Preston , David Sidransky
- Applicant Address: US MD Baltimore
- Assignee: The Johns Hopkins University
- Current Assignee: The Johns Hopkins University
- Current Assignee Address: US MD Baltimore
- Agency: Johns Hopkins Technology Transfer
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C40B30/04

Abstract:
The present invention provides methods of determination of a global DNA methylation index (GDMI) in a sample from a subject, using a variety of methods which can detect global, genome-wide, and gene-specific DNA methylation to create methylation portraits that can be used for early detection, diagnosis, and clinical management in the personalized medicine space. Further, the invention provides methods of diagnosis of cancer, including gastric cancer and hepatocellular cancer in a subject, by comparing the GDMI in a sample obtained from a subject to the methylation index of standard controls. These methods allow diagnosis of gastric carcinoma and liver cancer in patients who may be asymptomatic or have inconclusive pathology, and allowing earlier treatment of the subject.
Public/Granted literature
- US20130035247A1 GLOBAL DNA HYPOMETHYLATION AND BIOMARKERS FOR CLINICAL INDICATIONS IN CANCER Public/Granted day:2013-02-07
Information query